{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T20:40:15Z","timestamp":1794948015722,"version":"4.9.1"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T00:00:00Z","timestamp":1747180800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T00:00:00Z","timestamp":1747180800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["#NRF-2022R1A2B5B01001430 & NRF-2021R1F1A1045550"],"award-info":[{"award-number":["#NRF-2022R1A2B5B01001430 & NRF-2021R1F1A1045550"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Exp Mol Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Diffuse-type gastric cancer (DGC), characterized by poorly cohesive cells within fibrotic stroma, is associated with advanced disease and poor prognosis. Here, to identify distinct biomarkers for DGC compared with intestinal-type gastric cancer, we constructed a comprehensive large-scale signaling network using RNA-sequencing data from three genomic databases (The Cancer Genome Atlas, GSE62254 and GSE26253), developed a mathematical model and conducted simulation analyses. For validation, we used tissue microarray blocks of gastric cancers with immunohistochemical staining, single-cell RNA sequencing, primary cultures of cancer-associated fibroblasts (CAFs) and organoids, and a co-culture system involving CAFs and cancer cells. Signaling network analysis identified six differentially activated signaling components across the database, including <jats:italic>BIRC5<\/jats:italic>, <jats:italic>TTK<\/jats:italic>, <jats:italic>NEK2<\/jats:italic>, <jats:italic>FHL1<\/jats:italic>, <jats:italic>NR2F1<\/jats:italic> and <jats:italic>FBLN5<\/jats:italic>. Among the differentially activated signaling components, high tumoral expression of fibulin-5 protein encoded by <jats:italic>FBLN5<\/jats:italic> correlated with poor overall and disease-specific survival rates in patients with DGC, even after adjusting for the tumor, node, metastases (TNM) stage. Fibulin-5, derived from CAFs within DGC stroma, promoted organoid growth and epithelial\u2013mesenchymal transition (EMT) in DGC cell lines via the cAMP response element-binding protein (CREB) pathway in a CAF co-culture system. <jats:italic>FBLN5<\/jats:italic> knockdown in CAFs reduced the aggressive phenotype of co-cultured DGC cells, while CREB inhibitors reversed EMT. Furthermore, levels of secreted FBLN5 in patient blood samples correlated with its expression in primary tumors. In summary, fibulin-5 secreted by CAFs and interacted with DGC cells promotes EMT and is clinically associated with poor patient outcomes. These findings suggest fibulin-5 as a potential prognostic marker and therapeutic target in patients with DGC.<\/jats:p>","DOI":"10.1038\/s12276-025-01447-8","type":"journal-article","created":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T08:20:00Z","timestamp":1747210800000},"page":"1106-1119","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Cancer-associated fibroblast-derived fibulin-5 promotes epithelial\u2013mesenchymal transition in diffuse-type gastric cancer via cAMP response element-binding protein pathway, showing poor prognosis"],"prefix":"10.1038","volume":"57","author":[{"given":"Jinju","family":"Choi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoonjin","family":"Kwak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miree","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeong Yeon","family":"Jo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun Hyuk","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kook","family":"Myeong-Cherl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3983-6193","authenticated-orcid":false,"given":"Hang-Rae","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gwanghun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seong-Ho","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Do-Joong","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1667-7986","authenticated-orcid":false,"given":"Hye Seung","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyuk-Joon","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jung Mogg","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang Gyun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han-Kwang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji Kon","family":"Ryu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soo-Jeong","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,14]]},"reference":[{"key":"1447_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung, H. et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 71, 209\u2013249 (2021).","journal-title":"CA Cancer J. Clin."},{"key":"1447_CR2","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1111\/apm.1965.64.1.31","volume":"64","author":"P Lauren","year":"1965","unstructured":"Lauren, P. The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma. An attempt at a histo-clinical classification. Acta Pathol. Microbiol Scand. 64, 31\u201349 (1965).","journal-title":"Acta Pathol. Microbiol Scand."},{"key":"1447_CR3","doi-asserted-by":"publisher","first-page":"11","DOI":"10.7704\/kjhugr.2022.0072","volume":"22","author":"J-H Kim","year":"2022","unstructured":"Kim, J.-H. Diffuse-type gastric cancer. Korean J. Helicobacter Up. Gastrointest. Res. 22, 11\u201317 (2022).","journal-title":"Korean J. Helicobacter Up. Gastrointest. Res."},{"key":"1447_CR4","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1101\/gad.186965.112","volume":"26","author":"JS Logue","year":"2012","unstructured":"Logue, J. S. & Morrison, D. K. Complexity in the signaling network: insights from the use of targeted inhibitors in cancer therapy. Genes Dev. 26, 641\u2013650 (2012).","journal-title":"Genes Dev."},{"key":"1447_CR5","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-02160-5","volume":"8","author":"M Choi","year":"2017","unstructured":"Choi, M., Shi, J., Zhu, Y., Yang, R. & Cho, K. H. Network dynamics-based cancer panel stratification for systemic prediction of anticancer drug response. Nat. Commun. 8, 1940 (2017).","journal-title":"Nat. Commun."},{"key":"1447_CR6","first-page":"141","volume":"13","author":"M Saberi Anvar","year":"2018","unstructured":"Saberi Anvar, M., Minuchehr, Z., Shahlaei, M. & Kheitan, S. Gastric cancer biomarkers; a systems biology approach. Biochem. Biophys. Rep. 13, 141\u2013146 (2018).","journal-title":"Biochem. Biophys. Rep."},{"key":"1447_CR7","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1007\/s00432-009-0644-y","volume":"136","author":"YY Wang","year":"2010","unstructured":"Wang, Y. Y., Ye, Z. Y., Zhao, Z. S., Tao, H. Q. & Li, S. G. Systems biology approach to identification of biomarkers for metastatic progression in gastric cancer. J. Cancer Res. Clin. Oncol. 136, 135\u2013141 (2010).","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"1447_CR8","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1038\/nm.3850","volume":"21","author":"R Cristescu","year":"2015","unstructured":"Cristescu, R. et al. Molecular analysis of gastric cancer identifies subtypes associated with distinct clinical outcomes. Nat. Med. 21, 449\u2013456 (2015).","journal-title":"Nat. Med."},{"key":"1447_CR9","doi-asserted-by":"crossref","unstructured":"The Cancer Genome Atlas Research Network. Comprehensive molecular characterization of gastric adenocarcinoma. Nature 513, 202\u2013209 (2014).","DOI":"10.1038\/nature13480"},{"key":"1447_CR10","doi-asserted-by":"publisher","first-page":"52","DOI":"10.21037\/tgh.2020.01.02","volume":"5","author":"P Iyer","year":"2020","unstructured":"Iyer, P., Moslim, M., Farma, J. M. & Denlinger, C. S. Diffuse gastric cancer: histologic, molecular, and genetic basis of disease. Transl. Gastroenterol. Hepatol. 5, 52 (2020).","journal-title":"Transl. Gastroenterol. Hepatol."},{"key":"1447_CR11","doi-asserted-by":"publisher","unstructured":"Machlowska, J., Baj, J., Sitarz, M., Maciejewski, R. & Sitarz, R. Gastric cancer: epidemiology, risk factors, classification, genomic characteristics and treatment strategies. Int. J. Mol. Sci. https:\/\/doi.org\/10.3390\/ijms21114012 (2020).","DOI":"10.3390\/ijms21114012"},{"key":"1447_CR12","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1136\/gutjnl-2018-317645","volume":"69","author":"M Maeda","year":"2020","unstructured":"Maeda, M. et al. Cancer cell niche factors secreted from cancer-associated fibroblast by loss of H3K27me3. Gut 69, 243\u2013251 (2020).","journal-title":"Gut"},{"key":"1447_CR13","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-019-0972-8","volume":"18","author":"IH Ham","year":"2019","unstructured":"Ham, I. H. et al. Targeting interleukin-6 as a strategy to overcome stroma-induced resistance to chemotherapy in gastric cancer. Mol. Cancer 18, 68 (2019).","journal-title":"Mol. Cancer"},{"key":"1447_CR14","doi-asserted-by":"publisher","first-page":"6556","DOI":"10.1158\/1078-0432.CCR-17-1679","volume":"24","author":"SJ Cho","year":"2018","unstructured":"Cho, S. J. et al. KMT2C mutations in diffuse-type gastric adenocarcinoma promote epithelial-to-mesenchymal transition. Clin. Cancer Res. 24, 6556\u20136569 (2018).","journal-title":"Clin. Cancer Res."},{"key":"1447_CR15","doi-asserted-by":"publisher","first-page":"D548","DOI":"10.1093\/nar\/gkv1048","volume":"44","author":"L Perfetto","year":"2016","unstructured":"Perfetto, L. et al. SIGNOR: a database of causal relationships between biological entities. Nucleic Acids Res. 44, D548\u2013D554 (2016).","journal-title":"Nucleic Acids Res."},{"key":"1447_CR16","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1016\/S0960-9822(95)00151-5","volume":"5","author":"M Karin","year":"1995","unstructured":"Karin, M. & Hunter, T. Transcriptional control by protein phosphorylation: signal transmission from the cell surface to the nucleus. Curr. Biol. 5, 747\u2013757 (1995).","journal-title":"Curr. Biol."},{"key":"1447_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10930-017-9696-z","volume":"36","author":"V Singh","year":"2017","unstructured":"Singh, V. et al. Phosphorylation: implications in cancer. Protein J. 36, 1\u20136 (2017).","journal-title":"Protein J."},{"key":"1447_CR18","doi-asserted-by":"publisher","DOI":"10.1038\/srep02651","volume":"3","author":"J Reimand","year":"2013","unstructured":"Reimand, J., Wagih, O. & Bader, G. D. The mutational landscape of phosphorylation signaling in cancer. Sci. Rep. 3, 2651 (2013).","journal-title":"Sci. Rep."},{"key":"1447_CR19","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1161\/01.RES.0000149568.85071.FB","volume":"95","author":"AD Nguyen","year":"2004","unstructured":"Nguyen, A. D. et al. Fibulin-5 is a novel binding protein for extracellular superoxide dismutase. Circ. Res 95, 1067\u20131074 (2004).","journal-title":"Circ. Res"},{"key":"1447_CR20","doi-asserted-by":"publisher","first-page":"1839","DOI":"10.1093\/brain\/awr076","volume":"134","author":"M Auer-Grumbach","year":"2011","unstructured":"Auer-Grumbach, M. et al. Fibulin-5 mutations link inherited neuropathies, age-related macular degeneration and hyperelastic skin. Brain 134, 1839\u20131852 (2011).","journal-title":"Brain"},{"key":"1447_CR21","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1038\/415168a","volume":"415","author":"H Yanagisawa","year":"2002","unstructured":"Yanagisawa, H. et al. Fibulin-5 is an elastin-binding protein essential for elastic fibre development in vivo. Nature 415, 168\u2013171 (2002).","journal-title":"Nature"},{"key":"1447_CR22","doi-asserted-by":"publisher","first-page":"1578","DOI":"10.1002\/stem.3287","volume":"38","author":"SY Won","year":"2020","unstructured":"Won, S. Y. et al. Fibulin 5, a human Wharton\u2019s jelly-derived mesenchymal stem cells-secreted paracrine factor, attenuates peripheral nervous system myelination defects through the Integrin\u2013RAC1 signaling axis. Stem Cells 38, 1578\u20131593 (2020).","journal-title":"Stem Cells"},{"key":"1447_CR23","doi-asserted-by":"publisher","unstructured":"Mahajan, D. et al. Role of fibulins in embryonic stage development and their involvement in various diseases. Biomolecules https:\/\/doi.org\/10.3390\/biom11050685 (2021).","DOI":"10.3390\/biom11050685"},{"key":"1447_CR24","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1016\/S1995-7645(14)60137-1","volume":"7","author":"XY Shi","year":"2014","unstructured":"Shi, X. Y. et al. Effect of fFibulin-5 on cell proliferation and invasion in human gastric cancer patients. Asian Pac. J. Trop. Med 7, 787\u2013791 (2014).","journal-title":"Asian Pac. J. Trop. Med"},{"key":"1447_CR25","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1007\/s12079-009-0065-3","volume":"3","author":"H Yanagisawa","year":"2009","unstructured":"Yanagisawa, H., Schluterman, M. K. & Brekken, R. A. Fibulin-5, an integrin-binding matricellular protein: its function in development and disease. J. Cell Commun. Signal. 3, 337\u2013347 (2009).","journal-title":"J. Cell Commun. Signal."},{"key":"1447_CR26","doi-asserted-by":"publisher","unstructured":"Bian, X. et al. Clinical and biological significances of FBLN5 in gastric cancer. Cancers https:\/\/doi.org\/10.3390\/cancers15020553 (2023).","DOI":"10.3390\/cancers15020553"},{"key":"1447_CR27","first-page":"19725","volume":"9","author":"X Leng","year":"2016","unstructured":"Leng, X., Yang, C., Xiong, B. & Hou, J. Increased expression of Fibulin-5 in gastric cancer associated with poor prognosis. Int. J. Clin. Exp. Med. 9, 19725\u201319732 (2016).","journal-title":"Int. J. Clin. Exp. Med."},{"key":"1447_CR28","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1038\/s41392-021-00641-0","volume":"6","author":"F Wu","year":"2021","unstructured":"Wu, F. et al. Signaling pathways in cancer-associated fibroblasts and targeted therapy for cancer. Signal Transduct. Target. Ther. 6, 218 (2021).","journal-title":"Signal Transduct. Target. Ther."},{"key":"1447_CR29","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1038\/s41568-019-0238-1","volume":"20","author":"E Sahai","year":"2020","unstructured":"Sahai, E. et al. A framework for advancing our understanding of cancer-associated fibroblasts. Nat. Rev. Cancer 20, 174\u2013186 (2020).","journal-title":"Nat. Rev. Cancer"},{"key":"1447_CR30","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1093\/jnci\/djy234","volume":"111","author":"C Strell","year":"2019","unstructured":"Strell, C. et al. Impact of epithelial\u2013stromal interactions on peritumoral fibroblasts in ductal carcinoma in situ. J. Natl Cancer Inst. 111, 983\u2013995 (2019).","journal-title":"J. Natl Cancer Inst."},{"key":"1447_CR31","doi-asserted-by":"publisher","first-page":"2583","DOI":"10.1158\/1078-0432.CCR-08-1137","volume":"15","author":"KM Sakamoto","year":"2009","unstructured":"Sakamoto, K. M. & Frank, D. A. CREB in the pathophysiology of cancer: implications for targeting transcription factors for cancer therapy. Clin. Cancer Res. 15, 2583\u20132587 (2009).","journal-title":"Clin. Cancer Res."},{"key":"1447_CR32","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.ccell.2019.01.007","volume":"35","author":"J Cooper","year":"2019","unstructured":"Cooper, J. & Giancotti, F. G. Integrin signaling in cancer: mechanotransduction, stemness, epithelial plasticity, and therapeutic resistance. Cancer Cell 35, 347\u2013367 (2019).","journal-title":"Cancer Cell"}],"container-title":["Experimental &amp; Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s12276-025-01447-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s12276-025-01447-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s12276-025-01447-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,2]],"date-time":"2025-06-02T08:37:45Z","timestamp":1748853465000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s12276-025-01447-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,14]]},"references-count":32,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2025,5]]}},"alternative-id":["1447"],"URL":"https:\/\/doi.org\/10.1038\/s12276-025-01447-8","relation":{},"ISSN":["2092-6413"],"issn-type":[{"value":"2092-6413","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,14]]},"assertion":[{"value":"27 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 January 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 February 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 May 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}